{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:36:05Z","timestamp":1792632965417,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01LM012100"],"award-info":[{"award-number":["K01LM012100"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA108456"],"award-info":[{"award-number":["T32CA108456"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001320","name":"RPCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008603","name":"UPCI","doi-asserted-by":"publisher","award":["P50CA159981-01A1"],"award-info":[{"award-number":["P50CA159981-01A1"]}],"id":[{"id":"10.13039\/100008603","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006398","name":"Roswell Park Alliance Foundation, Roswell Park Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ygyno.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T09:46:30Z","timestamp":1494236790000},"page":"52-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5636-0812","authenticated-orcid":false,"given":"Kevin H.","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Starbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Spring-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Cleason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"Zsiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brian","family":"Szender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ygyno.2017.05.005_bb0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.005_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO committee on gynecologic oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2017.05.005_bb0015","series-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"World Health Organization","year":"2014"},{"issue":"8","key":"10.1016\/j.ygyno.2017.05.005_bb0020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.005_bb0025","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.05.005_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1756-0500-6-88","article-title":"Peritoneal tuberculosis mimicking advanced ovarian carcinoma: an important differential diagnosis to consider","volume":"6","author":"Gosein","year":"2013","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.ygyno.2017.05.005_bb0035","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"8","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.ygyno.2017.05.005_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006014.pub5","article-title":"Interval debulking surgery for advanced epithelial ovarian cancer","volume":"6","author":"Tangjitgamol","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.005_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","article-title":"\u201cOptimal\u201d cytoreduction for advanced epithelial ovarian cancer: a commentary","volume":"103","author":"Eisenkop","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.005_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrclinonc.2015.26","article-title":"A framework for a personalized surgical approach to ovarian cancer","volume":"12","author":"Nick","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.ygyno.2017.05.005_bb0055","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.18632\/oncotarget.3746","article-title":"Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome","volume":"6","author":"Auer","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ygyno.2017.05.005_bb0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"21\u221222","key":"10.1016\/j.ygyno.2017.05.005_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10354-014-0323-8","article-title":"Epithelial ovarian cancer\u2014more data, more questions?","volume":"164","author":"Aust","year":"2014","journal-title":"Wien. Med. Wochenschr."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.005_bb0070","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2013.07.016","article-title":"A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer","volume":"209","author":"Fagotti","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.005_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"34","key":"10.1016\/j.ygyno.2017.05.005_bb0080","doi-asserted-by":"crossref","first-page":"36308","DOI":"10.18632\/oncotarget.6121","article-title":"On representing the prognostic value of continuous gene expression biomarkers with the restricted mean survival curve","volume":"6","author":"Eng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2017.05.005_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7819-8-11","article-title":"Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?","volume":"8","author":"Mousavi","year":"2010","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.005_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"9990","key":"10.1016\/j.ygyno.2017.05.005_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ygyno.2017.05.005_bb0100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.05.005_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.05.005_bb0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817308442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817308442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T06:43:40Z","timestamp":1575614620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817308442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0090825817308442"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}